Early feasibility study results are promising for AltaValve, which is designed with a novel atrial fixation system to ...
The AltaValve transcatheter mitral valve replacement (TMVR) system had sustained effects among patients with severe mitral regurgitation out to 1 year, according to an early feasibility study (EFS).
TAMPA, Fla. (WFLA) — Tampa General Hospital is breaking down medical barriers. The hospital is the first and only hospital in the Southeast to complete a Transcatheter Mitral Valve Replacement with a ...
Tampa General is one of just five health care institutions in the nation to offer AltaValve as an alternative to open-heart surgery. "At Tampa General, we're pioneering new technologies that can save ...
MINNEAPOLIS, May 8, 2024 /PRNewswire/ -- 4C Medical Technologies, Inc. ("4C Medical"), a medical device company dedicated to advancing minimally invasive therapies for structural heart disease, has ...
TCT 812: Stentless strategy for a patient with unstable angina involving the left main trunk scheduled for invasive treatment for hepatocellular carcinoma Receive the the latest news, research, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results